Xencor Statistics
NASDAQ: XNCRHealth CareBiotechnology: Pharmaceutical PreparationsUSD
33.26-0.75 (-2.21%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Xencor by the numbers
Xencor has a market capitalization of $2.50 billion based on 75.04M shares outstanding. With trailing EPS of $-1.56, Xencor is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 17.7% above its 50-day average and 78.1% above its 200-day average.
Average daily trading volume is 1.54M shares, or about $51.2 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
XNCR valuation vs. peer median
| Metric | XNCR | Peer median | Difference |
|---|---|---|---|
| Market cap | $2.50B | $2.33B | +7% |
| Avg. volume | 1.54M | 844.89K | +82% |
Peer median across 8 companies: IDYA, MBX, ZLAB, PBH, HCM, RCUS, PHVS, PRGO.
Valuation
- Market cap
- $2.50B
- Price / sales (latest FY)
- 19.87
- EPS (TTM)
- $-1.56
- Shares outstanding
- 75.04M
Price and trading
- Previous close
- 34.01
- Open
- 33.41
- Day range
- 33.12 – 34.27
- 52-week range
- 10.38 – 40.60
- 52-week change
- +109.58%
- Beta
- —
- Volume
- 1.22M
- Average volume
- 1.54M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 4, 2026
Additional statistics
- Market Cap
- 2.50B
- Forward Pe
- -8.81
- Eps
- -1.56
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 40.60
- Week52 Low
- 10.38
- Avg Volume
- 1.54M
- Shares Outstanding
- 75.04M
- Ma50
- 28.26
- Ma200
- 18.67
- Earnings Date
- Nov 4, 2026
- Pct From52w High
- -18.08%
- Pct From52w Low
- 220.58%